Physician profile
William L Moore
NPI 1548342454
$1,677.29
in general payments reported to CMS, 2019-2025
19 companies · $713 in 2025
The $713 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.73 · 2020: $15.04 · 2021: $17.16 · 2022: $119 · 2023: $237 · 2024: $488 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $363.58 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $237.28 | 2020-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Glaxosmithkline, LLC. | $153.48 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Ironshore Pharmaceuticals INC. | $136.39 | 2024 | |
| Sanofi-Aventis U.S. LLC | $122.61 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $99.20 | 2025 | Jornay Pm |
| Corium, LLC | $98.95 | 2022-2024 | Azstarys |
| Acadia Pharmaceuticals INC | $96.81 | 2023-2025 | Daybue, Nuplazid |
| Seqirus USA INC | $71.91 | 2024-2025 | Flucelvax |
| Sanofi Pasteur INC. | $70.65 | 2021-2024 | |
| Cranial Technologies, INC | $58.55 | 2024 | Doc Band |
| Genentech USA, INC. | $27.90 | 2019 | |
| Sobi, INC | $23.88 | 2023 | |
| Rhythm Pharmaceuticals, INC. | $23.35 | 2025 | Imcivree |
| Neurocrine Biosciences, INC. | $21.56 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $18.77 | 2019 | |
| Kaleo, INC. | $18.23 | 2023 | Auvi-Q |
| Phadia US INC. | $17.92 | 2022 | |
| Alk-Abello, INC | $16.27 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.